Slingshot Insights | Immunomic Therapeutics Overview

IMMUNOMIC THERAPEUTICS Overview

Upcoming Projects (IMMUNOMIC THERAPEUTICS)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (IMMUNOMIC THERAPEUTICS)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (IMMUNOMIC THERAPEUTICS)

FDA Grants Fast Track Designation for Astellas (ALPMY) and Immunomic Therapeutics' ASP0892 for the Mitigation of Severe Hypersensitivity Reactions due to Peanut Allergy
Tickers: ALPMY, Immunomic Therapeutics
Occurred on: Dec 20, 2016

Strategic Initiatives (IMMUNOMIC THERAPEUTICS)

Don’t see a strategic initiative related to the company you care about? Create your own!